Company: IPGP
Filing Date: 2025-04-07
Form Type: DEF 14A
Source: 0001111928-25-000054
Chunk: 43

Company: IPG PHOTONICS CORP
Filing Date: 2025-04-07
Form: DEF 14A
Chunk 43
---
 (200% vesting) |     |    | Results |     |      | % Vesting |
| Operating Cash Flow to Adjusted Net Income (Ratio) |     |               | 58 | % |     | 83 | %              |     | 108 | %              |     | 75 | %       |     | 66.3 | %         |

The following table shows the relative TSR performance assessment beginning on the grant date of March 1, 2021 and ending on March 1, 2024.

| Measurement                                       
 Three-year relative TSR (beginning March 1, 2021) 
 (% of index performance)                          |     |              |     | 75 | Minimum      
 (0% vesting) 
 %            |     | 100 | Target         
 (100% vesting) 
 %              |     | 150 | Maximum        
 (200% vesting) 
 %              | TSR of (66.82)% |     | Actual Result |     | — | % Vesting 
 %         |
|:--------------------------------------------------|:----|:-------------|:----|:---|:-------------|:----|:----|:---------------|:----|:----|:---------------|:----------------|:----|:--------------|:----|:--|:----------|
|                                                   |     | TSR of 7.48% |     |    | TSR of 9.97% |     |     | TSR of 14.96%  |     |     |                |                 |     |               |     |   |           |

Half of PSUs granted in 2022 (which vested in 2025) were based upon organic revenue growth and half were based on average adjusted operating margin over a three-year performance period beginning January 1, 2022 and ending December 31, 2024. As three-year performance was below threshold for PSUs granted in 2022, the NEOs did not earn any payouts on the performance-based long-term incentives vesting in March 2025.

The following graphic shows payouts compared to targets for PSUs granted in 2017 (vesting in 2020) to 2022 (vesting in 2025), demonstrating the strong connection between pay and performance in the Company's long-term incentive compensation practices.

41

#### 2024 Compensation of Named Executive Officers

#### Compensation Related to Leadership Transitions
The Board appointed Dr. Gitin as CEO of the Company, effective June